• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthheart disease

This Tiny Robot Team Could Help Stop the No. 1 Killer in America

By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
January 12, 2016, 9:29 AM ET
Print
MinJun Kim/Bastlabs.org

This year a few mice are set to become the first patients for a brand-new kind of heart disease treatment.

It’s a surgery being performed by tiny microsurgeons. The surgeons, called nanorobots, are really tiny groups of magnetically charged particles that band together to break up clogged arteries.

The robot molecules work on blockages in two stages. First they deliver drugs that help soften clogged arteries. Then they charge into battle, drilling in to blast heart blockages apart.

Biomedical engineer MinJun Kim, a professor at Drexel University, is part of the international team of scientists from the U.S., Switzerland, and South Korea who are working on the tech. He says the robots are controlled by harnessing the power of magnetic resonance imaging (MRI), the tunnel-like machines more commonly used for X-ray imaging in hospitals. Working with the nanobots, the MRI machines can serve as a kind of command and control center: both steering and observing the magnetically charged bots as they navigate their way around inside the body.

https://youtu.be/WwjUDsHu5R0

Kim’s already tried this out in the lab. But it’s a strategy that still needs some fine-tuning before human trials. The nanobots need to perfect their drilling techniques. The plan is to try that out this summer with mice at a national hospital in South Korea. Then the team will move on to testing in rabbits and pigs. If all goes well, by 2019 they’ll be launching the bots into humans (via catheter injection).

Many have tried for years to build nanobots that can serve as minisurgeons inside the body. The robots have been touted as potential solutions for detecting cancer and helping out with eye surgery. Google’s new Verily, the life sciences division of Alphabet, started its own partnership with Johnson & Johnson (JNJ) on surgical robots in 2015 dubbed “Verb Surgical.” But little’s known about how far along Google (GOOGL) might be with its surgical bots, and there haven’t been any other definitive human trial results just yet.

SIGN UP: Get Data Sheet, Fortune’s daily newsletter about the business of technology.

Surgeons are already using bigger external robots to assist with heart surgeries. By remote-controlling robotic arms, the doctors can make smaller incisions and more precise movements than they’d be able to using human hands.

WATCH: Surgery goes robotic:

When it comes to the tiny nanobot models that Kim and his team are working on, though, he says “the smaller the better.” That way, after arteries have been blasted and unclogged, the molecules can just swim off the job and biodegrade.

About the Author
By Hilary Brueck
See full bioRight Arrow Button Icon

Latest in Health

Julian Braithwaite is the Director General of the International Alliance for Responsible Drinking
CommentaryProductivity
Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite
By Julian BraithwaiteDecember 13, 2025
7 minutes ago
Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
2 hours ago
Healthmeal delivery
Factor Meals Review 2025: Tester Approved
By Christina SnyderDecember 12, 2025
17 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
18 hours ago
HelloFresh meal delivery service.
Healthmeal delivery
HelloFresh Review : We Tasted Everything so You Don’t Have To
By Christina SnyderDecember 12, 2025
19 hours ago
Noom as best weight loss program
HealthWeight Loss
Noom Review (2025): Everything You Need to Know
By Christina SnyderDecember 12, 2025
20 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
23 hours ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
22 hours ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
18 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
17 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.